Data Show Treatment With Remicade(R) Reduced Hospitalizations For Ulcerative Colitis Patients By Half

... Patients with ulcerative colitis (UC) treated with REMICADE(R) (infliximab) had an approximate 50 percent reduction in mean number of hospitalizations per year compared with placebo, according to an analysis of long-term data from a Phase 3 clinical trial (Active Ulcerative Colitis Trial 1, ACT 1) presented at the American College of Gastroenterology (ACG) meeting. [click link for full article] ...